| Identification | Back Directory | [Name]
Benzamide, 2-[[2-[[4-[4-(3-aminopropyl)-1-piperazinyl]phenyl]amino]-5-chloro-4-pyrimidinyl]amino]-N-methyl- | [CAS]
2135595-04-7 | [Synonyms]
GSK3182571
Benzamide, 2-[[2-[[4-[4-(3-aminopropyl)-1-piperazinyl]phenyl]amino]-5-chloro-4-pyrimidinyl]amino]-N-methyl- | [Molecular Formula]
C25H31ClN8O | [MDL Number]
MFCD28386192 | [MOL File]
2135595-04-7.mol | [Molecular Weight]
495.02 |
| Chemical Properties | Back Directory | [density ]
1.298±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 100 mg/mL (202.01 mM; ultrasonic and adjust pH to 4 with HCl) | [form ]
Solid | [pka]
14.57±0.46(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Biological Activity]
GSK3182571 is a non-speci?c kinase inhibitor[1]. | [storage]
Store at -20°C | [References]
[1]. Mikhail M Savitski, et al. Tracking cancer drugs in living cells by thermal profiling of the proteome. Science. 2014 Oct 3;346(6205):1255784. |
|
|